The Evidence Base recently featured a ‘deep dive’ analysis of this ISPOR 2024 presentation.
_
Disparities in health outcomes and access to health care among different population groups are becoming increasingly important to be considered in health technology assessment (HTA) and reimbursement decision-making. To ensure that health inequalities are appropriately and systematically considered by all stakeholders, there is a need for a clear framework, better methods to measure inequality, and a shared understanding of how these factors should be considered alongside clinical outcomes.
In the ISPOR 2024 session titled, “Payer Perceptions of Health Inequalities in Reimbursement Decision Making: Implications for the Pharmaceutical Industry,” Kuldeep Singh and Tijana Ignjatovic of Genesis Research Group delved into this complex landscape. They shared results from a qualitative payer survey on perceptions of health equity and its role in decision-making, providing valuable insights into current stakeholder views on this critical issue.
Access full article
_
The survey was carried out using our RPR stakeholder engagement solution. If you’d like to learn more about this, please get in touch via this form or email solutions@genesisrg.com.
